世界の性欲低下障害（HSDD）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4340
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、性欲低下障害（HSDD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブスピロン、ブプロピオン、テストステロン、フリバンセリン、ブレメラノチド、認知行動療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・性欲低下障害（HSDD）治療の市場動向
・企業の競争状況、市場シェア
・性欲低下障害（HSDD）治療の種類別市場規模と予測2016-2027（ブスピロン、ブプロピオン、テストステロン、フリバンセリン、ブレメラノチド、認知行動療法）
・性欲低下障害（HSDD）治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・性欲低下障害（HSDD）治療の北米市場規模2016-2027（アメリカ、カナダ）
・性欲低下障害（HSDD）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・性欲低下障害（HSDD）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・性欲低下障害（HSDD）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・性欲低下障害（HSDD）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AMAG Pharmaceuticals、Allergan, Plc.、Ivix LLX、EndoCeutics, Inc.、Emotional Brain BV、S1 Biopharma, Inc.、Sprout Pharmaceuticals, Inc.）
・結論

Hypoactive sexual desire disorder (HSDD) is the absence of sexual thoughts and fantasies causing low libido and sex drive in women population worldwide.

Market Analysis and Insights: Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
The global Hypoactive Sexual Desire Disorder (HSDD) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market.

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Scope and Market Size
Hypoactive Sexual Desire Disorder (HSDD) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Buspirone
Bupropion
Testosterone
Flibanserin
Bremelanotide
Cognitive Behavior Therapy

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AMAG Pharmaceuticals
Allergan, Plc.
Ivix LLX
EndoCeutics, Inc.
Emotional Brain BV
S1 Biopharma, Inc.
Sprout Pharmaceuticals, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Buspirone
1.2.3 Bupropion
1.2.4 Testosterone
1.2.5 Flibanserin
1.2.6 Bremelanotide
1.2.7 Cognitive Behavior Therapy
1.3 Market by Application
1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2016-2027)
2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Regions
2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Dynamic
2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue
3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2016-2021)
3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2020
3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2022-2027)

5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
6.2.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
6.2.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
6.2.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
6.3.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
6.3.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
6.3.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
6.4.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
6.4.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
7.2.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
7.3.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
7.4.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
8.2.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
8.3.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region
8.4.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
9.2.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
9.3.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
9.4.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
10.2.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
10.3.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
10.4.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Details
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.1.5 AMAG Pharmaceuticals Recent Development
11.2 Allergan, Plc.
11.2.1 Allergan, Plc. Company Details
11.2.2 Allergan, Plc. Business Overview
11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.2.5 Allergan, Plc. Recent Development
11.3 Ivix LLX
11.3.1 Ivix LLX Company Details
11.3.2 Ivix LLX Business Overview
11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.3.5 Ivix LLX Recent Development
11.4 EndoCeutics, Inc.
11.4.1 EndoCeutics, Inc. Company Details
11.4.2 EndoCeutics, Inc. Business Overview
11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.4.5 EndoCeutics, Inc. Recent Development
11.5 Emotional Brain BV
11.5.1 Emotional Brain BV Company Details
11.5.2 Emotional Brain BV Business Overview
11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.5.5 Emotional Brain BV Recent Development
11.6 S1 Biopharma, Inc.
11.6.1 S1 Biopharma, Inc. Company Details
11.6.2 S1 Biopharma, Inc. Business Overview
11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.6.5 S1 Biopharma, Inc. Recent Development
11.7 Sprout Pharmaceuticals, Inc.
11.7.1 Sprout Pharmaceuticals, Inc. Company Details
11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
11.7.5 Sprout Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Buspirone
Table 3. Key Players of Bupropion
Table 4. Key Players of Testosterone
Table 5. Key Players of Flibanserin
Table 6. Key Players of Bremelanotide
Table 7. Key Players of Cognitive Behavior Therapy
Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2016-2021)
Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2022-2027)
Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players (2016-2021)
Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2020)
Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. AMAG Pharmaceuticals Company Details
Table 66. AMAG Pharmaceuticals Business Overview
Table 67. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 68. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 69. AMAG Pharmaceuticals Recent Development
Table 70. Allergan, Plc. Company Details
Table 71. Allergan, Plc. Business Overview
Table 72. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 73. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 74. Allergan, Plc. Recent Development
Table 75. Ivix LLX Company Details
Table 76. Ivix LLX Business Overview
Table 77. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 78. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 79. Ivix LLX Recent Development
Table 80. EndoCeutics, Inc. Company Details
Table 81. EndoCeutics, Inc. Business Overview
Table 82. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 83. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 84. EndoCeutics, Inc. Recent Development
Table 85. Emotional Brain BV Company Details
Table 86. Emotional Brain BV Business Overview
Table 87. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 88. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 89. Emotional Brain BV Recent Development
Table 90. S1 Biopharma, Inc. Company Details
Table 91. S1 Biopharma, Inc. Business Overview
Table 92. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 93. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 94. S1 Biopharma, Inc. Recent Development
Table 95. Sprout Pharmaceuticals, Inc. Company Details
Table 96. Sprout Pharmaceuticals, Inc. Business Overview
Table 97. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 98. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
Table 99. Sprout Pharmaceuticals, Inc. Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Buspirone Features
Figure 3. Bupropion Features
Figure 4. Testosterone Features
Figure 5. Flibanserin Features
Figure 6. Bremelanotide Features
Figure 7. Cognitive Behavior Therapy Features
Figure 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
Figure 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2022-2027)
Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2020
Figure 18. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2020
Figure 20. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
Figure 24. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
Figure 25. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
Figure 26. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
Figure 30. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
Figure 31. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
Figure 32. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2016-2027)
Figure 42. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 62. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 63. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 64. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 65. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 66. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 67. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

女性用性的欲求低下障害治療のグローバル市場調査 2019年

Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Professional Survey Report 2019
QYR9NV04704 2019年11月12日 105Pages
※本調査レポートは、女性用性的欲求低下障害治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011...

世界の破壊的行動障害（DBD）治療市場規模・現状・予測（2021年-2027年）

Global Disruptive Behavior Disorder (DBD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4142 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、破壊的行動障害（DBD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、心理療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年）

Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5740 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、女性性機能障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能...

世界の物質使用障害治療市場規模・現状・予測（2021年-2027年）

Global Substance Use Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4914 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、物質使用障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルコール乱用治療、ニコチン乱用治療、薬物乱用治療）、用途別市場規模（病院、クリニック、在宅医療設備）、主要地域別市場規模（北米、アメリ...

世界の網膜障害治療市場規模・現状・予測（2021年-2027年）

Global Retinal Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4826 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジェル、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の結核（TB）治療市場規模・現状・予測（2021年-2027年）

Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4987 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、結核（TB）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イソニアジド、リファンピン（リファディン、リマクタン）、エタンブトール（ミアンブトール）、ピラジナミド）、用途別市場規模（活動性結核、潜...

世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

Global Microscopic Polyangiitis(MPA) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4506 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、顕微鏡的多発血管炎（MPA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年）

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の慢性難治性咳（CRC）治療市場規模・現状・予測（2021年-2027年）

Global Chronic Refractory Cough (CRC) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5661 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、慢性難治性咳（CRC）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（言語療法、理学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の原始神経外胚葉性腫瘍（PNET）治療市場規模・現状・予測（2021年-2027年）

Global Primitive Neuroectodermal Tumors (PNET) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4766 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、原始神経外胚葉性腫瘍（PNET）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科手術、化学療法、放射線療法）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリ...

女性用性的欲求低下障害治療のグローバル市場調査 2019年 The global Female Hypoactive Sexual Desire Disorder Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Female Hypoactive Sexual Desire Disorder Therapeutics volume and value at global leve…
世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年） Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
世界の破壊的行動障害（DBD）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Disruptive Behavior Disorder (DBD) Treatment Market The global Disruptive Behavior Disorder (DBD) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…